Abstract
The development of imaging probes based on advances in nanotechnology aims to substantially improve specificity and sensitivity of diagnostic imaging through non-invasive and quantitative detection of specific biomolecules in living subjects. A promising class of molecular imaging probes consists of nanoparticles (NPs) functionalized with a certain targeting agent. Such targeting agents can, for instance, be selected to recognize disease-related biomarkers located on the cell surface. Among the possible agents that direct the NPs to the target site, aptamers, being single-stranded DNA or RNA molecules that can be designed to bind preselected targets such as proteins and peptides with high affinity and specificity, play an increasingly important role. Indeed, aptamers selected against proteins or whole cells have been conjugated to a variety of nanomaterials (NMs) such as Au NPs, quantum dots (QD), and superparamagnetic iron oxide NPs (SPIONs). These probes have successfully been used for cell imaging, both in vitro and in vivo, by optical imaging, magnetic resonance imaging (MRI), computed tomography (CT), and positron-emission tomography (PET). This review presents an overview of the commonly used techniques involved in conjugating aptamer to NPs and their application as probes in cellular or in vivo imaging.
Keywords: Aptamer, aptamer-conjugated nanoparticles, conjugation, medical imaging, diagnosis, nanoparticles
Current Topics in Medicinal Chemistry
Title:Conjugation Approaches for Construction of Aptamer-Modified Nanoparticles for Application in Imaging
Volume: 13 Issue: 4
Author(s): Jung Hwan Lee
Affiliation:
Keywords: Aptamer, aptamer-conjugated nanoparticles, conjugation, medical imaging, diagnosis, nanoparticles
Abstract: The development of imaging probes based on advances in nanotechnology aims to substantially improve specificity and sensitivity of diagnostic imaging through non-invasive and quantitative detection of specific biomolecules in living subjects. A promising class of molecular imaging probes consists of nanoparticles (NPs) functionalized with a certain targeting agent. Such targeting agents can, for instance, be selected to recognize disease-related biomarkers located on the cell surface. Among the possible agents that direct the NPs to the target site, aptamers, being single-stranded DNA or RNA molecules that can be designed to bind preselected targets such as proteins and peptides with high affinity and specificity, play an increasingly important role. Indeed, aptamers selected against proteins or whole cells have been conjugated to a variety of nanomaterials (NMs) such as Au NPs, quantum dots (QD), and superparamagnetic iron oxide NPs (SPIONs). These probes have successfully been used for cell imaging, both in vitro and in vivo, by optical imaging, magnetic resonance imaging (MRI), computed tomography (CT), and positron-emission tomography (PET). This review presents an overview of the commonly used techniques involved in conjugating aptamer to NPs and their application as probes in cellular or in vivo imaging.
Export Options
About this article
Cite this article as:
Lee Jung Hwan, Conjugation Approaches for Construction of Aptamer-Modified Nanoparticles for Application in Imaging, Current Topics in Medicinal Chemistry 2013; 13 (4) . https://dx.doi.org/10.2174/1568026611313040010
DOI https://dx.doi.org/10.2174/1568026611313040010 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance
Current Gene Therapy Cruciferous Plants: Phytochemical Toxicity Versus Cancer Chemoprotection
Mini-Reviews in Medicinal Chemistry Systems Cytogenomics: Are We Ready Yet?
Current Genomics The Role of the Endoplasmic Reticulum in the Accumulation of β-Amyloid Peptide in Alzheimers Disease
Current Molecular Medicine Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells
Recent Patents on Anti-Cancer Drug Discovery New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry Harnessing Phage Display for the Discovery of Peptide-Based Drugs and Monoclonal Antibodies
Current Medicinal Chemistry Current Status Of Short Synthetic Peptides As Vaccines
Medicinal Chemistry Plasticity of Neuroendocrine-Immune Interactions During Ontogeny: Role of Perinatal Programming in Pathogenesis of Inflammation and Stress- Related Diseases in Adults
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Efficacy and Safety of Combined Radiotherapy with EGFR Inhibitors and Chemotherapy for Laryngeal Organ Preservation in Patients with Locally Advanced Hypopharyngeal Carcinomas
Current Cancer Drug Targets The Blood-Brain/Tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery
Current Pharmaceutical Biotechnology Cytotoxic, Apoptotic and DNA Synthesis Inhibitory Effects of Some Thiazole Derivatives
Letters in Drug Design & Discovery Current Development in Encapsulated Cell Therapy for Degenerative Retinopathies
Current Tissue Engineering (Discontinued) Cancer Invasion and Metastasis: Discovering New Targets For Diagnosis and Therapeutics
Current Signal Transduction Therapy Microemulsions and Nanoemulsions for Targeted Drug Delivery to the Brain
Current Nanoscience Elevated Levels of Bilirubin and Long-Term Exposure Impair Human Brain Microvascular Endothelial Cell Integrity
Current Neurovascular Research Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis
Current Pharmaceutical Design Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design